Acting CDER Director Patrizia Cavazzoni may have to think more about aducanumab, but Acting US FDA Commissioner Janet Woodcock is front of mind for Wall Street analysts. • Source: photo illustration
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
